The effect of SATB1 on the EGFR level and the progression of non-small cell lung cancers
2017/25/N/NZ5/01651
Keywords
Descriptors
- NZ5_7: Leczenie chorób człowieka
- NZ5_5: Diagnostyka chorób człowieka
- NZ5_3: Patogeneza chorób człowieka
Panel
NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution
Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej, Wydział Lekarski
Voivodeship: dolnośląskie
Principal investigator (from the host institution)
Natalia Małgorzata Glatzel-Plucińska
Number of co-investigators in the project: 3
Call
PRELUDIUM 13 – announced on 2017-03-15
- Amount awarded
- 179 880 PLN
- Project start date
- 2018-01-26
- Project end date
- 2023-01-25
- Project duration
- 60 months (the same as in the proposal)
- Project status
- Project settled
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (1)
-
EGFR Levels in NSCLC Are Associated With Expression of SATB1 and EMT‐promoting Factors
- Authors:
- Natalia Glatzel-Plucińska, Aleksandra Piotrowska, Mateusz Olbromski, Adam Rzechonek, Marzenna Podhorska-Okołów, Piotr Dzięgiel
- Status:
- Accepted for publication